Earlier this month, WeightWatchers made the extraordinary announcement that it would be offering its own version of the 'fat ...

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

The agency posted documents this week that the drugmaker had requested the drug be placed on the FDA's "Demonstrable ...

Bernstein said Novo Nordisk (NVO) study results that showed certain Rybelsus users had a 14% risk reduction for major ...

SURVEY SAYS: Just 18% of the health-care plans sponsored by employers with 200 workers or more cover such drugs, according to ...

WEIGHT-LOSS jabs are the most talked about drugs of the moment. And with new studies popping up almost every week revealing ...

A late-stage study shows that Novo Nordisk's oral semaglutide, Rybelsus, cuts the risk of MACE by 14% in T2D patients ...

Research hints that medications like Zepbound and Wegovy could provide new ways to treat opioid and alcohol abuse.

MangoRx said it “strongly refutes” claims made by Eli Lilly that it improperly copied blockbuster weight-loss medicines for ...

Advocates argue that anti-obesity drugs like Ozempic could help overweight troops, but the services have no uniform policy ...

The oral semaglutide reduced the occurrence of major adverse cardiovascular events (MACE) by 14% in patients with T2D.

You’ve probably heard about the dramatic weight loss that can happen when you take Ozempic or Wegovy. These medications mimic ...